Thank you for your interest in our Ulcerative Colitis clinical trial!

Clinical trials are for the development of new medications seeking FDA approval. Qualified participants have access to free medical care and cutting-edge medications and often receive $50-$75 per office visit for their time and travel.

About The Trial: The Ulcerative Colitis clinical trial lasts from 3-8 years and is ongoing with the possibility of an extension. 

 About Ulcerative Colitis: Ulcerative Colitis, is one of the two primary forms of idiopathic inflammatory bowel disease (IBD). The most common symptoms include bloody diarrhea associated with rectal urgency. Very often patients will be completely symptom free and then relapse to have symptoms again.